Virulence and antimicrobial resistance gene profiling in multidrug-resistant Pseudomonas aeruginosa with evaluation of levofloxacin and amikacin therapy | Synapse
March 3, 2026
Virulence and antimicrobial resistance gene profiling in multidrug-resistant Pseudomonas aeruginosa with evaluation of levofloxacin and amikacin therapy
Puntos clave
The study reveals a significant prevalence of virulence and antimicrobial resistance genes in Pseudomonas aeruginosa strains.
Key evidence indicates that levofloxacin and amikacin exhibit varying levels of effectiveness against these resistant strains.
Laboratory evaluation assessed the impact of treatment strategies on drug effectiveness and resistance patterns.
The findings highlight the need for continuous surveillance and tailored therapies due to rising multidrug resistance.